EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dexamethasone Induces Senescence-Associated Changes in Trabecular Meshwork Cells by Increasing ROS Levels Via the TGFβ/Smad3-NOX4 Axis

Haijun Li, Jing Ren, Huiling Cui, Di Wang, Rumeng Zhao, Xiaohui Liu, Shuai Tian, Jing Wang, Jingyi Zhang, Peng Li iD, Rick F Thorne, Shichao Duan iD

Cell Transplantation · 2023-01 · 32

DOI: 10.1177/09636897231177356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Transplantation, online erschienen am 02.06.2023. Verfasst von Haijun Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Henan Provincial People's Hospital, Henan Eye Institute, Henan Eye Hospital, Zhengzhou University People's Hospital, Henan University People's Hospit…. Hauptthemen laut MEDLINE: NADPH Oxidases, Glaucoma. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Henan Medical Science and technology research plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glaucoma is a serious complication of glucocorticoid (GC) therapy arising through elevations in intraocular pressure (IOP). Dexamethasone (DEX) is reported to contribute to elevated IOP through different effects on the trabecular meshwork but whether DEX contributes to glaucoma development through the induction of cellular senescence is still unclear. We explored the actions of DEX on transformed human trabecular meshwork cells (HTMCs) using RNA-seq and conducted bioinformatic analyses to determine the affected pathways. Among the 4,103 differentially expressed genes identified in transformed HTMCs treated with 400 nM DEX (2,036 upregulated and 2,067 downregulated genes, respectively), bioinformatic analyses revealed significant enrichment and potential interplay between the transforming growth factor beta (TGFβ)41; signaling and cellular senescence pathways. DEX treatment induced senescence changes in primary and transformed HTMCs as indicated by increases in SA-β-gal positivity, interleukin (IL)-6 secretion, and senescence-associated heterochromatin foci (SAHF) along with selective accumulation of senescence marker p15 and elevations in reactive oxygen species (ROS) levels. Notably, the DEX-induced senescence changes were rescued by treatment with the TGFβ/Smad3 pathway inhibitor SIS3. Furthermore, we show that DEX increases cellular ROS levels via upregulation of NADPH oxidase 4 (NOX4) through activation of Smad3, and that SIS3 decreases ROS levels by downregulating NOX4. Instructively, inhibiting NOX4 with GLX351322 and scavenging ROS with NAC were both effective in preventing DEX-induced senescence changes. Similarly, we found in the mouse model that DEX-ac upregulated p15 and NOX4 expression in the trabecular meshwork, with cotreatment with GLX351322 alleviating elevations in IOP. We establish that DEX induces senescence changes in HTMCs by increasing ROS levels via the TGFβ/Smad3/NOX4 axis, increasing IOP and contributing to glaucoma development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NADPH OxidasesGlaucomaAnimalsMiceHumansReactive Oxygen SpeciesTrabecular MeshworkTransforming Growth Factor betaCells, CulturedDexamethasoneSmad3 ProteinNADPH Oxidase 4

Stichwörter der Autor:innen

NOX4ROSSmad3dexamethasonesenescencetrabecular meshwork

Substanzen

NADPH OxidasesReactive Oxygen SpeciesTransforming Growth Factor betaDexamethasoneSMAD3 protein, humanSmad3 ProteinNOX4 protein, humanNADPH Oxidase 4Nox4 protein, mouse

Autor:innen und Institutionen

  • Henan Provincial People's Hospital, Henan Eye Institute, Henan Eye Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, China.
  • Translational Research Institute, Henan Provincial People's Hospital, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
  • Henan Provincial People's Hospital, Zhengzhou, China.
  • College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
  • Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Peng Li, Shichao Duan

Förderung

  • National Natural Science Foundation of China
  • Henan Medical Science and technology research plan

Zitieren

APA

Li, H., Ren, J., Cui, H., Wang, D., Zhao, R., Liu, X., Tian, S., Wang, J., Zhang, J., Li, P., Thorne, R. F., & Duan, S. (2023). Dexamethasone Induces Senescence-Associated Changes in Trabecular Meshwork Cells by Increasing ROS Levels Via the TGFβ/Smad3-NOX4 Axis. Cell Transplantation, 32. https://doi.org/10.1177/09636897231177356

Vancouver

Li H, Ren J, Cui H, Wang D, Zhao R, Liu X, et al. Dexamethasone Induces Senescence-Associated Changes in Trabecular Meshwork Cells by Increasing ROS Levels Via the TGFβ/Smad3-NOX4 Axis. Cell Transplantation. 2023;32. doi:10.1177/09636897231177356

BibTeX
@article{Li2023,
  author = {Li, Haijun and Ren, Jing and Cui, Huiling and Wang, Di and Zhao, Rumeng and Liu, Xiaohui and Tian, Shuai and Wang, Jing and Zhang, Jingyi and Li, Peng and Thorne, Rick F and Duan, Shichao},
  title = {Dexamethasone Induces Senescence-Associated Changes in Trabecular Meshwork Cells by Increasing ROS Levels Via the TGFβ/Smad3-NOX4 Axis},
  journal = {Cell Transplantation},
  year = {2023},
  volume = {32},
  doi = {10.1177/09636897231177356}
}
Kostenlos starten →